Vista 300/Vista 300 S +5 more— 510(k) K252250

Substantially Equivalent

Shanghai Draeger Medical Instrument Co., Ltd.

FDA 510(k) clearance K252250 for Vista 300/Vista 300 S +5 more, Substantially Equivalent on 2026-04-10. Applicant: Shanghai Draeger Medical Instrument Co., Ltd.. Device class: 2.

Summary

This filing covers the Vista 300 and Vista 300 S patient monitors in five US configurations, split between non-invasive and invasive models. Product code MHX is for physiological patient monitors with arrhythmia detection or alarms: the bedside monitors that show ECG, SpO2, blood pressure, and related vitals.

Class II, 21 CFR 870.1025. The Cardiovascular panel reviewed it as a Traditional 510(k).

The applicant is Shanghai Draeger Medical Instrument, the Chinese arm of Germany's Drägerwerk, filing from Shanghai. Review took 267 days (July 17, 2025 to April 10, 2026). Clearing every configuration of a monitor platform in one submission is common practice.

Clearance details

Device name as filed
Vista 300/Vista 300 S; Vista 300 Non-Inv Model A, US (2601064); Vista 300 Invasive Model C, US (2601065); Vista 300 S Non-Inv Model A, US (2602425); Vista 300 S Invasive Model B, US (2602426); Vista 300 S Invasive Model C, US (2602427)
Applicant
Shanghai Draeger Medical Instrument Co., Ltd.
Product code
Code MHX
Device class
Class 2
Regulation
21 CFR 870.1025
Advisory panel
Cardiovascular
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Shanghai, CN
Download summary PDFView on FDA.gov ↗

Recent devices under product code MHX

view all

More clearances from Shanghai Draeger Medical Instrument Co., Ltd.

view all

Adverse events under product code MHX

product code MHX
Death
580
Injury
2,441
Malfunction
12,655
Other
3
Total
15,679

Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.